G. Picarda

M. Heymann, D. Heymann, F. Gouin, 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Loss of connexin43 expression in Ewing's sarcoma cells favors the development of the primary tumor and the associated bone osteolysis.

F. Tirode, F. Verrecchia, D. Heymann, 2013, Biochimica et biophysica acta.

Preclinical Evidence that Use of TRAIL in Ewing's Sarcoma and Osteosarcoma Therapy Inhibits Tumor Growth, Prevents Osteolysis, and Increases Animal Survival

O. Delattre, F. Tirode, P. Delépine, 2010, Clinical Cancer Research.

Animal Models of Malignant Primary Bone Tumors and Novel Therapeutic Approaches

F. Gouin, J. Rousseau, F. Redini, 2010 .

Therapeutic efficacy of soluble receptor activator of nuclear factor-kappa B-Fc delivered by nonviral gene transfer in a mouse model of osteolytic osteosarcoma

B. Pitard, D. Heymann, J. Rousseau, 2010 .

Profiling Human Cytomegalovirus-Specific T Cell Responses Reveals Novel Immunogenic Open Reading Frames

Sandeep Kumar Dhanda, J. Sidney, A. Sette, 2021, Journal of virology.

Profiling Human Cytomegalovirus-Specific T Cell Responses Reveals Novel Immunogenic Open Reading Frames

Sandeep Kumar Dhanda, J. Sidney, A. Sette, 2021, bioRxiv.

Structure of human cytomegalovirus UL144, an HVEM orthologue, bound to the B and T cell lymphocyte attenuator

C. Benedict, D. Zajonc, T. Doukov, 2019, The Journal of Biological Chemistry.

Cytomegalovirus: Shape-Shifting the Immune System

C. Benedict, G. Picarda, Gaëlle Picarda, 2018, The Journal of Immunology.

Unique phenotypes and clonal expansions of human CD4 effector memory T cells re-expressing CD45RA

Julie G. Burel, J. Greenbaum, Bjoern Peters, 2017, Nature Communications.

Unique phenotypes and clonal expansions of human CD4 effector memory T cells re-expressing CD45RA

Julie G. Burel, J. Greenbaum, Bjoern Peters, 2017, Nature Communications.

Osteoprotegerin inhibits bone resorption and prevents tumor development in a xenogenic model of Ewing's sarcoma by inhibiting RANKL

F. Tirode, M. Heymann, B. Pitard, 2013, Journal of bone oncology.

N-glycosylation of mouse TRAIL-R and human TRAIL-R1 enhances TRAIL-induced death

C. Benedict, T. Gharbi, C. Garrido, 2017, Cell Death and Differentiation.

Interleukin-17D and Nrf2 mediate initial innate immune cell recruitment and restrict MCMV infection

C. Benedict, Joseph C. Sun, Nicholas M. Adams, 2018, Scientific Reports.

Impact of onco-pediatric dosing regimen of zoledronic acid on bone growth: Preclinical studies and case report of an osteosarcoma pediatric patient

M. Heymann, D. Heymann, F. Gouin, 2011 .

Therapeutic efficacy of soluble receptor activator of NF-kB (RANK) delivered by non viral gene transfer in a mouse model of osteolytic osteosarcoma

B. Pitard, D. Heymann, J. Rousseau, 2008 .

P47. Therapeutic efficacy of soluble receptor activator of NF-kappaB delivered by non-viral gene transfer in a mouse model of osteolytic osteosarcoma

B. Pitard, D. Heymann, J. Rousseau, 2008 .